David Shaw’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.3M Sell
133,100
-100,000
-43% -$26.5M 0.03% 638
2026
Q1
$25.5M Buy
233,100
+65,400
+39% +$9.31M 0.02% 1002
2025
Q4
$27.9M Buy
167,700
+27,600
+20% +$4.62M 0.02% 1029
2025
Q3
$27.4M Buy
140,100
+15,900
+13% +$2.61M 0.02% 970
2025
Q2
$11.2M Buy
124,200
+75,700
+156% +$5.98M 0.01% 1406
2025
Q1
$2.89M Buy
48,500
+3,500
+8% +$324K ﹤0.01% 2330
2024
Q4
$5.96M Buy
+45,000
New +$4.22M ﹤0.01% 1835

Other funds holding ALAB

David Shaw's ALAB Position: Q2 2026 in Review

David Shaw reduced its Astera Labs (ALAB) stake by 55% in Q2 2026, selling an estimated $223M and leaving 680,298 shares worth $329M. The position accounts for 0.16% of the portfolio, ranked #120.

David Shaw first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $499M in Q3 2025. 984 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • David Shaw held 680,298 shares of Astera Labs worth $329M as of Q2 2026.
  • David Shaw sold 839,263 Astera Labs shares in Q2 2026, an estimated $223M.
  • Astera Labs made up 0.16% of David Shaw's portfolio in Q2 2026, its #120 holding.
  • David Shaw first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • David Shaw's Astera Labs position peaked at $499M in Q3 2025.
  • 984 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.